Cover Image
市場調查報告書

歐洲的醫藥品、醫療產業 (季度更新報告)

Europe Pharmaceuticals and Healthcare Report Q3 2017

出版商 BMI Research 商品編碼 363589
出版日期 內容資訊 英文 45 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
歐洲的醫藥品、醫療產業 (季度更新報告) Europe Pharmaceuticals and Healthcare Report Q3 2017
出版日期: 2017年07月12日 內容資訊: 英文 45 Pages
簡介

本報告提供歐洲各國的製藥產業及醫療產業相關分析,地區整體產業規模的實際成果值、預測值 (過去5年、今後10年份) 估計,產業的課題 (風險) 和未來性的商機 (利潤) 相關評估,域內各地區的詳細趨勢,主要企業簡介等資訊彙整,為您概述為以下內容

BMI產業分析

  • 歐洲市場最新形勢

SWOT分析

  • 歐洲市場最新形勢

產業預測

  • 醫藥品市場最新形勢
  • 醫療市場最新形勢

產業的風險/利潤指標

  • 歐洲:風險/利潤指標

市場概況

  • 歐洲市場最新形勢

產業的趨勢與發展

  • 歐洲市場最新形勢

域內市場概況

  • 歐洲市場最新形勢

詞彙表

分析方法

  • 醫藥品支出額的預測模式
  • 醫療費的預測模式
  • 分析方法的相關註記
  • 風險/利潤指標技術
  • 指標概要
  • 指標的加權

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 2398-1024

BMI View: The outlooks for the emerging and developed European sub-regions are divergent. In Western Europe, cost-containment policies will remain prominent, limiting the growth opportunities from increased demand for chronic disease medicines through ageing populations. In emerging Europe, market growth will be robust, driven by the rapid expansion of healthcare access.

Headline Expenditure Projections

  • Pharmaceuticals: USD320.7bn in 2016 to USD313.4bn in 2017; -2.3% in US dollar terms. Forecast revised downwards from last quarter.
  • Healthcare: USD1,852bn in 2016 to USD1,814bn in 2016; -2.1% in US dollar terms. Forecast revised downwards from last quarter.

Risk/Reward Index

Europe is a region with a high degree of variability of market attractiveness for innovative drugmakers. Western Europe is the home to some of the most attractive pharmaceutical markets globally, however while some markets in emerging Europe represent high growth potential and/or favourable regulatory environments, others will continue to pose significant challenges due to weak patent enforcement or weak purchasing power. It is vital that companies appreciate the varying levels of both investment risk and reward that are present in the markets in Europe. BMI's Innovative Pharmaceuticals Risk/Reward Index tool, which provides a globally comparative and numerically based assessment of a market's attractiveness for companies looking to launch a high-value drug, was established to address this.

Table of Contents

  • BMI Industry View
    • Table: Headline Regional Pharmaceuticals & Healthcare Forecasts (2015-2021)
  • SWOT
  • Industry Forecast
  • Pharmaceutical Market Forecast
    • Table: Regional Pharmaceutical Sales, Historical Data And Forecasts Europe (Region) 2013-2021
  • Healthcare Market Forecast
    • Table: Regional Healthcare Expenditure Trends, Historical Data And Forecasts Europe (Region) 2013-2021
  • Industry Risk Reward Index
  • Western Europe Risk/Reward Index
  • Central And Eastern Europe Risk/Reward Index - Q3 2017
  • Market Overview
  • Industry Trend Analysis
  • Regional Themes - Europe
  • Industry Trends & Developments
  • Regional Round-Up
    • Table: Europe Pharmaceutical Market (USDbn)
  • Glossary
  • Methodology
  • Pharmaceutical Expenditure Forecast Model
  • Healthcare Expenditure Forecast Model
  • Notes On Methodology
  • Risk/Reward Index Methodology
    • Table: Indicators - Rationale And Sources
Back to Top